Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Refractory Polymyalgia Rheumatica
NCT01423591Phase 3Unknown
- Sponsor
- Marqués de Valdecilla University Hospital
- Start
- Jun 2007
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in polymyalgia rheumatica (PMR), sponsored by Marqués de Valdecilla University Hospital. Status: unknown.
02
Drugs
infliximab
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT01423591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423591.